Froniter Biotechnologies
68822117.702.91% ( +0.50 )
Froniter Biotechnologies (688221)
Frontier Biotechnologies Inc., a commercial-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes various medicines that improv...
- Open
- 17.65
- High
- 18.19
- Low
- 17.61
- Prev. Close
- 17.20
- Volume
- 130.71K
- Turnover
- 234.23M
- Avg Price
- 17.92
- Bid/Ask Ratio
- --
- Amplitude
- 3.37%
- 52wk High
- 29.98
- Volume Ratio
- 0.48
- Turnover Ratio
- 3.49%
Froniter Biotechnologies Analyst Rating
View MoreForecast & Rating
Mar 9, 2026Price forecast
¥15.80-10.73%
Forecast & RatingBuy
1analysts
- Strong buy0.00%
- Buy100.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Yicai · Feb 25 at 04:21 AM
China’s Frontier Biotech Wipes Out Gains Despite USD1 Billion Drug Licensing Deal With GSK
- prnewswire · Feb 25 at 02:25 AM
03:24 ETFrontier Biotech und GSK schließen globale Exklusivlizenzvereinbarung für therapeutische Anwendungen mit kleinen interferierenden RNAs
- TradingView · Feb 24 at 07:03 PM
Key facts: GSK signs $1B deal for RNA therapies; completes buyback of 2.2M shares
- prnewswire · Feb 24 at 04:57 AM
05:55 ETFrontier Biotech and GSK Enter Global Exclusive Licensing Agreement for Small Interfering RNA Therapeutics
- Wallstreetcn · Jan 8 at 11:26 PM
The A-share innovative drug sector surged in the afternoon, with WECOME rising over 15%, Frontier Biotechnologies and SHANGHAI YIZHONG rising over 10%, and JLPC, Hongbo Pharmaceutical, Genrix Bio, and Chengda Pharmaceutical following suit
- Zhitong · Sep 21, 2025 at 08:36 PM
The chemical pharmaceutical sector rose in early trading, with SUNFLOWER hitting the daily limit of a 20cm increase
